AI Real-Time Intraoperative Pathology System PathLens Receives FDA Approval: 30-Second Pathological Diagnosis During Surgery
PathAI's intraoperative real-time pathology analysis system PathLens receives FDA approval, enabling surgeons to obtain AI-assisted pathological diagnosis results in 30 seconds during surgery, eliminating the 30-minute wait for traditional frozen sections
AI Real-Time Intraoperative Pathology System PathLens Receives FDA Approval: 30-Second Pathological Diagnosis During Surgery
PathAI announced on November 4 that its intraoperative real-time pathology analysis system PathLens has received FDA approval. PathLens uses high-resolution spectral imaging and an AI analysis engine to enable surgeons to obtain pathological diagnosis results in just 30 seconds during surgery, compared to the 30-minute wait required for traditional frozen sections.
PathLens works by placing excised tissue samples on a dedicated spectral imaging platform, where the AI analyzes the tissue's molecular characteristics in 30 seconds and provides benign/malignant determinations and margin status assessments. In clinical trials involving 12,000 surgeries, PathLens achieved a diagnostic accuracy of 97.2%, slightly higher than the 95.8% of traditional frozen sections.
PathLens's impact on surgical workflow is revolutionary — surgeons no longer need to pause mid-surgery waiting for pathology results and can make immediate surgical decisions based on real-time diagnostic information. PathLens is estimated to reduce average surgery time by 40 minutes.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.